Global Targeted Drug Delivery Market Size Report Segmented by Technology (Nanoparticles, Liposomes, ADCs), Route of Administration (Injectable, Oral, Pulmonary, Transdermal, Nasal), Application (Oncology, CVDs, Neurological Disorders), Regional Forecast to 2031

1. Introduction
   • Introduction
   • Market Scope
     • Market Definition
     • Segments Covered
     • Regional Segmentation
   • Research Timeframe
   • Currency Considered
   • Study Limitations
   • Stakeholders
   • List of Abbreviations
   • Key Conferences and Events (2026-2027)
2. Research Methodology
   • Secondary Research
   • Primary Research
   • Market Estimation
     • Bottom-Up Approach
     • Top-Down Approach
   • Market Forecasting
3. Executive Summary
   • Targeted Drug Delivery Market Snapshot (2026-2031)
   • Segment Overview
   • Regional Snapshot
   • Competitive Insights
5. Expansion of biologics, gene therapies, and RNA therapeutics
6. Increasing success of antibody-drug conjugates (ADCs) technologies
7. Restraints
   • High development and manufacturing costs
   • Complex regulatory requirements
   • Safety and toxicity concerns
   • Limited accessibility in cost-sensitive markets
8. Opportunities
   • Expansion beyond oncology
   • Increasing demand for specialized CDMO services
   • Emerging market penetration
   • Development of next-generation delivery platforms
9. Key Market Trends
   • Increasing adoption of antibody-drug conjugates (ADCs)
   • Growing use of lipid nanoparticle (LNP) delivery systems
   • Development of stimulus-responsive drug delivery platforms
   • Expansion of exosome-based drug delivery technologies
10. Unmet Market Needs
11. Industry Speaks
< start="5">
12. Global Targeted Drug Delivery Market Size & Forecast (2024-2031), By Technology, USD Billion
    • Introduction
    • Nanoparticles
    • Liposomes
    • Antibody-drug Conjugates (ADCs)
    • Microspheres and Microcapsules
    • Other Technologies
13. Global Targeted Drug Delivery Market Size & Forecast (2024-2031), By Route of Administration, USD Billion
    • Introduction
    • Injectable
    • Oral
    • Pulmonary
    • Transdermal
    • Nasal
    • Other Delivery Routes
14. Global Targeted Drug Delivery Market Size & Forecast (2024-2031), By Application, USD Billion
    • Introduction
    • Oncology
    • Cardiovascular Diseases (CVDs)
    • Neurological Disorders
    • Infectious Diseases
    • Respiratory Diseases
    • Metabolic Disorders
    • Other Applications
15. Global Target Market Size & Forecast (2024-2031), By End User, USD Billion
    • Introduction
    • Pharmaceutical and Biotechnology Companies
    • Research and Academic Institutes
    • Hospitals and Clinics
    • Other End Users
"9">
16. Global Targeted Drug Delivery Market Size & Forecast (2024-2031), By Region, USD Billion
    • Introduction
    • North America Targeted Drug Delivery Market Size & Forecast (2024-2031), By Country, USD Billion
      • US
        • Market Size & Forecast, By Technology (USD Billion)
        • Market Size & Forecast, By Route of Administration (USD Billion)
        • Market Size & Forecast, By Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • Canada
        • Market Size & Forecast, By Technology (USD Billion)
        • Market Size & Forecast, By Route of Administration (USD Billion)
        • Market Size & Forecast, By Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
    • Europe Targeted Drug Delivery Market Size & Fory Technology (USD Billion)
    • Market Size & Forecast, By Route of Administration (USD Billion)
    • Market Size & Forecast, By Application (USD Billion)
    • Market Size & Forecast, By End User (USD Billion)
17. Germany
    • Market Size & Forecast, By Technology (USD Billion)
    • Market Size & Forecast, By Route of Administration (USD Billion)
    • Market Size & Forecast, By Application (USD Billion)
    • Market Size & Forecast, By End User (USD Billion)
18. France
    • Market Size & Forecast, By Technology (USD Billion)
    • Market Size & Forecast, By Route of Administration (USD Billion)
    • Market Size & Forecast, By Application (USD Billion)
    • Market Size & Forecast, By End User (USD Billion)
19. Italy
    • Market Size & Forecast, By Technology i>
    • Market Size & Forecast, By Application (USD Billion)
    • Market Size & Forecast, By End User (USD Billion)
20. Spain
    • Market Size & Forecast, By Technology (USD Billion)
    • Market Size & Forecast, By Route of Administration (USD Billion)
    • Market Size & Forecast, By Application (USD Billion)
    • Market Size & Forecast, By End User (USD Billion)
21. Rest of Europe
    • Market Size & Forecast, By Technology (USD Billion)
    • Market Size & Forecast, By Route of Administration (USD Billion)
    • Market Size & Forecast, By Application (USD Billion)
    • Market Size & Forecast, By End User (USD Billion)
22. Asia Pacific (APAC) Targeted Drug Delivery Market Size & Forecast (2024-2031), By Country, USD Billion
    • China
      • Market Size & Forecastration (USD Billion)
      • Market Size & Forecast, By Application (USD Billion)
      • Market Size & Forecast, By End User (USD Billion)
    • Japan
      • Market Size & Forecast, By Technology (USD Billion)
      • Market Size & Forecast, By Route of Administration (USD Billion)
      • Market Size & Forecast, By Application (USD Billion)
      • Market Size & Forecast, By End User (USD Billion)
    • India
      • Market Size & Forecast, By Technology (USD Billion)
      • Market Size & Forecast, By Route of Administration (USD Billion)
      • Market Size & Forecast, By Application (USD Billion)
      • Market Size & Forecast, By End User (USD Billion)
    • Rest of Asia Pacific
      • Market Size & Forecast, By Technology (USD Billion)
      • Market Size & Forecast, By Route of Adminisli>Market Size & Forecast, By End User (USD Billion)
23. Latin America (LATAM) Targeted Drug Delivery Market Size & Forecast (2024-2031), USD Billion
    • Market Size & Forecast, By Technology (USD Billion)
    • Market Size & Forecast, By Route of Administration (USD Billion)
    • Market Size & Forecast, By Application (USD Billion)
    • Market Size & Forecast, By End User (USD Billion)
24. Middle East & Africa (MEA) Targeted Drug Delivery Market Size & Forecast (2024-2031), USD Billion
    • Market Size & Forecast, By Technology (USD Billion)
    • Market Size & Forecast, By Route of Administration (USD Billion)
    • Market Size & Forecast, By Application (USD Billion)
    • Market Size & Forecast, By End "10">
    • Competitive Landscape
      • Key Players and their Competitive Positioning
        • Key Player Comparison
        • Segment-wise Player Mapping
        • Market Share Analysis (2025)
        • Company Categorization Matrix
          • Dominants/Leaders
          • New Entrants
          • Emerging Players
          • Innovative Players
        • Key Strategies Assessment, By Player (2023-2026)
          • New Product Launch & Approval
          • Partnerships, Agreements, & Collaborations
          • Mergers & Acquisitions
          • Geographic Expansion

11. Company Profiles*

(Business Overview, Financial Performance**, Products Offered, Recent Developments)

• AbbVie Inc.
• AstraZeneca
• Pfizer Inc.
• Baxter
• Boston Scientific Corporation
• Becton, Dickinson and Company (BD)
• Sanofi
• Hoffmann-La Roche Ltd
• Johnson & Johnson
• Arrowhead Pharmaceuticals, Inc.
• Other Prominent Players

Note: *Indicative list

**For listed companies